Gilead claims it has won the breast cancer trial, but offers few details; drug application is filed with the FDA – MedCity News
Gilead Sciences now has more clinical data showing that breast cancer drug Trodelvy has helped patients live longer. The FDA already has that data, too, as the drugmaker said Monday…